NCT00296933View on ClinicalTrials.gov

Memory Functioning and Antidepressant Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2005

Conditions
DepressionMajor Depressive Disorder
Interventions
DRUG

Escitalopram

DRUG

Bupropion XL

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

H. Lundbeck A/S

INDUSTRY

lead

University Health Network, Toronto

OTHER